A diagnosis is still about the same person forty years later.

Clinical data does not lose sensitivity over time: it describes a person, and the person is still there. This is the sector where the distance between secrecy term and technology term is most evident — and where part of the equipment producing the data has a longer life cycle than the software protecting it.

01Sector profile on the ruler

The comparison available

Cohort

42,096

companies · Healthcare

Sector median

69.3

High

Half the cohort between

65.476.5

p25 – p75

Standard deviation

9.93

σ

Distribution by band

  • Critical22.0%
  • High70.3%
  • Moderate7.7%

H · time horizon

0.9559

E · observable exposure

0.5807

Cohort medians at the cutoff date. H accounts for the shelf life of the data the cryptography protects; E, for the surface reachable from outside. Both describe the cohort, not your organization.

The healthcare cohort is one of the largest on the ruler and is heavily concentrated in the upper bands. The useful readout is not the sector's average position — it is internal dispersion: organizations in the same sector, under the same obligations, appear in quite different positions, which indicates room for decision where regulatory determinism is usually assumed.

The aggregates describe the cohort at the cutoff date, with an anonymity floor. No institution is identifiable in them.

What this comparison is measured against

Cutoff date
July 12, 2026
Run
producao_324k_20260712
Population
316,911 companies
Sectors
15 sectors in the engine taxonomy
Anonymity floor
K = 30

Limits of the comparison

  • The ruler is a static reference base, not a continuous measurement: there is no automatic update between one run and the next.
  • Comparison is always against anonymous aggregates, never against another organization's individual result.
  • A public-mode result does not compare to a complete-mode result, because the two readings start from different kinds of evidence.
02What distinguishes the sector

Healthcare combines permanently sensitive data, a device fleet with long replacement cycles, and an interoperability mesh — payers, labs, record systems, providers — that moves the same data across many boundaries.

  • Clinical data that identifies the person and does not lose relevance.
  • Equipment with a longer useful life than its embedded software.
  • Mandatory interoperability across many actors.
  • Care continuity that restricts maintenance windows.
03Data shelf life

The medical record is the clearest example of data whose sensitivity does not decay: clinical history, genetic testing, and diagnoses stay identifiable and sensitive for as long as the person lives — and in some cases beyond, because they also concern relatives.

  • Clinical history and electronic medical records.
  • Genetic results, which also concern relatives.
  • Images and reports stored for long periods.
  • Member data and utilization history.

Typical dependencies

  • Medical record and hospital management system vendors.
  • Device and connected equipment manufacturers.
  • Labs and payers in the interoperability mesh.
  • Telemedicine providers and digital care channels.
04The sector's HNDL context

Clinical traffic captured today would still reveal sensitive information when decrypted — there is no term after which a diagnosis stops identifying someone. Add a device fleet whose cryptographic replacement is not a configuration update, and the sector's exposure stops being a matter of posture and becomes one of structure.

05What applies

With sensitive data and a wide third-party mesh, an external readout and peer comparison are what fits without touching the care environment.

Exposure Report

In production

A readout with no agent, credentials, or maintenance window.

Sector Benchmark

In production

Position against the healthcare cohort, with percentile and band.

Third-party assessment

In production

Ranking the provider and vendor mesh by exposure.

The limits of this readout

  • The assessment is external and touches neither care systems nor devices in operation.
  • Medical devices with no public face are not in the collection.
  • IEQ does not assert compliance with health data protection regulation.
  • Sector medians authorize no conclusion about a specific institution.

Boundary

Where measurement ends

Adequacy programNot implemented

Measurement ends at: the technical change in the environment. Measuring exposure does not reduce it: reduction requires changing configuration, replacing certificates, switching negotiation policy, or migrating libraries — work carried out by the organization's own teams and suppliers.

This readout delivers

  • Public-surface exposure, without touching the care environment.
  • Position against the cohort and the sector's internal dispersion.
  • Deepening priorities across the third-party mesh.

After the change, GWK

  • Re-collects public signals and recalculates IEQ on the same ruler, when contracted to do so.
  • States scope, mode, coverage, and run for both measurements, so the difference is interpretable.
  • Attributes the observed effect only to the scope actually changed and verified.

Not included

  • Executing the change: GWK does not alter the client's configuration, certificates, or infrastructure.
  • Deployment, assisted operation, or change management.
  • An adequacy program: it exists as a GWK engineering project, not as a contractable capability.

Start without touching the environment

A public-signal readout requires no integration, agent, or maintenance window — which matters when the system serves patient care.